Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Filings indexed 382 across all filing types
Latest filing 2014-07-02 Capital/Financing Update
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the offering, the company, risk factors, use of proceeds, and financial statements. This type of filing is related to capital raising activities and financing updates. It is not an annual report, earnings release, or any other report type but specifically a registration statement for securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2014-07-02 English
Regulatory Filings 2014
Regulatory Filings
2014-06-20 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated May 22, 2014, for Sunshine Biopharma, Inc. It includes detailed information about the securities offering, company background, risk factors, use of proceeds, financial statements, and other disclosures typical of a registration statement for a public offering. The presence of terms like 'Registration Statement under the Securities Act of 1933', 'Prospectus', 'Offering Summary', and detailed financial and business information confirms this is a capital raising filing. This type of document is best classified as a Capital/Financing Update (CAP), which covers company fundraising and financing activities.
2014-05-22 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2014
2014-05-09 English
REQUEST TO WITHDRAW REGISTRATION STATEMENT
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to the SEC requesting the withdrawal of a previously filed registration statement on Form S-4. It references regulatory rules under the Securities Act and confirms that no securities were issued under the registration statement. The document is short (2366 characters) and is a regulatory communication rather than a financial report or announcement of results. It does not contain financial data, earnings, or management discussion. It is a regulatory filing related to the withdrawal of a registration statement, which fits best under the category of Regulatory Filings (RNS).
2014-04-29 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes entering into an Investment Agreement and a Registration Rights Agreement related to the sale of common stock, which are financing activities. There are no financial statements or detailed financial analysis present, only the announcement of these agreements. The document length is 4568 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Capital/Financing Update (CAP).
2014-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.